ArticleAmerican journal of translational research2024
Preoperative CT radiomic model combined with clinical and CT imaging features to predict the spread through air spaces in T1 invasive lung adenocarcinoma.
Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nomogram based on computed tomography fractal dimension for predicting spread through air spaces in lung adenocarcinoma.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to explore the effectiveness of preoperative computed tomography (CT) radiomic models combined with clinical and CT imaging features for predicting spread through air spaces (STAS) in patients with T1 lung adenocarcinoma.
methodsThe preoperative CT and clinical data of 219 patients with T1 invasive lung adenocarcinoma confirmed by surgery were retrospectively analyzed and randomly divided into training and test sets at a ratio of 7:3. Univariable and multivariable logistic analyses were performed on the clinical and CT manifestations to screen independent predictive factors for STAS (+), and a clinical model was constructed. Radiomic features were extracted from the tumor (T), peritumoral (P) and tumor-peritumoral (TP) regions to construct radiomic models (Model T, Model P and Model TP), and the optimal radiomic model was identified. A combined model was then built on the basis of the best radiomic score (Radscore) and clinically independent predictors. For each model, the effectiveness in predicting STAS (+) was assessed with receiver operating characteristic (ROC) curve analysis, including calculation of the area under the curve (AUC), and a nomogram was created. Calibration curve analysis was used to assess model calibration, and decision curve analysis (DCA) was used to evaluate the clinical value of the model.
resultsEmphysema, the preoperative carcinoembryonic antigen (CEA) level, and the consolidation tumor ratio (CTR) were identified as independent predictors of STAS (+) (all P < 0.01). Model T was considered the optimal radiomic model. In the training set, the AUC of the combined model was greater than that of the clinical model (0.93 vs. 0.85, P < 0.01). However, no significant difference in the AUC was found between the combined model and Model T (0.93 vs. 0.92, P > 0.05). In the test set, the AUC of the combined model was greater than that of the clinical model (0.92 vs. 0.85, P < 0.05), but there was no significant difference compared to the AUC of Model T (0.92 vs. 0.90, P = 0.13). The AUC of Model T was greater than that of the clinical model in the training set (0.92 vs. 0.85, P < 0.01), but this difference was not significant in the test set (0.90 vs. 0.85, P = 0.35). The clinical model, radiomic Model T, and combined model all had high degrees of calibration. Finally, the clinical net benefit of the combined model was greater than that of the other two models with the threshold ranged from 0.10 to 0.40.
conclusionThe preoperative CT radiomics model combined with clinical and CT imaging features can effectively predict STAS in T1 invasive lung adenocarcinoma patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.